These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23586435)

  • 1. Prostate-specific antigen screening for prostate cancer: why so much controversy?
    Labrie F
    Int J Urol; 2013 Nov; 20(11):1148. PubMed ID: 23586435
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 3. [Opportunity for a systematic screening of prostatic cancer by determining prostate specific antigen levels].
    Cuzin B; Maisonneuve H; Thoral F; Charvet-Protat S
    Prog Urol; 2000 Feb; 10(1):124-7. PubMed ID: 10785932
    [No Abstract]   [Full Text] [Related]  

  • 4. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
    Ito K
    Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
    [No Abstract]   [Full Text] [Related]  

  • 5. Upcoming evidences on prostate-specific antigen-based screening for men at risk of prostate cancer.
    Boscolo-Berto R
    Int J Urol; 2009 Sep; 16(9):711. PubMed ID: 19769655
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer screening.
    Catalona WJ
    BJU Int; 2004 Nov; 94(7):964-6. PubMed ID: 15541107
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Terris MK
    Eur Urol; 2009 Feb; 55(2):392; discussion 393. PubMed ID: 18353530
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.
    Shteynshlyuger A; Andriole GL
    J Urol; 2011 Mar; 185(3):828-32. PubMed ID: 21239021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate specific antigen and screening for early prostate cancer.
    Davidson P
    N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
    [No Abstract]   [Full Text] [Related]  

  • 10. To screen or not to screen? Prostate cancer screening: why it's not for every man.
    Lefevre M
    Medscape J Med; 2008; 10(8):181. PubMed ID: 18924633
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate-specific antigen (PSA) should drive doing prostate biopsies.
    Loeb S; Catalona WJ
    Urol Oncol; 2012; 30(1):1-2. PubMed ID: 21458316
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate specific antigen (PSA)-based screening.
    Suzuki H; Flanigan RC; Okuyama A;
    Int J Urol; 2008 Sep; 15(9):757-62. PubMed ID: 18786202
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostatitis and prostate cancer: implications for prostate cancer screening.
    Kawakami J; Siemens DR; Nickel JC
    Urology; 2004 Dec; 64(6):1075-80. PubMed ID: 15596172
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate specific antigen testing for the diagnosis of prostate cancer.
    McKenzie P; Delahunt B; deVoss K; Ross B; Tran H; Sikaris K
    Pathology; 2011 Aug; 43(5):403. PubMed ID: 21753713
    [No Abstract]   [Full Text] [Related]  

  • 15. Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan.
    Ito K; Kakehi Y; Naito S; Okuyama A;
    Int J Urol; 2008 Sep; 15(9):763-8. PubMed ID: 18786203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weighing the benefits and downsides of prostate-specific antigen screening.
    Pignone M
    Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer screening--is the controversy resolved?
    Norcross WA; Ganiats TG
    West J Med; 1995 Jul; 163(1):65-6. PubMed ID: 7545340
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.
    Yuen JS
    J Urol; 2004 Mar; 171(3):1246. PubMed ID: 14767320
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for prostate cancer--the controversy that refuses to die.
    Barry MJ
    N Engl J Med; 2009 Mar; 360(13):1351-4. PubMed ID: 19297564
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer.
    Barry MJ
    N Engl J Med; 2001 May; 344(18):1373-7. PubMed ID: 11333995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.